How is Actemrasupplied?

Dosage Forms And Strengths Single-use vials of ACTEMRA (20 mg per mL) for IV administration
  • 80 mg per 4 mL
  • 200 mg per 10 mL
  • 400 mg per 20 mL
Prefilled Syringe (PFS) for SC administration
  • A single-use prefilled glass syringe providing 162 mg of ACTEMRA in 0.9mL
Storage And Handling For Intravenous Infusion ACTEMRA (tocilizumab) is supplied in single-use vials as a preservative-free, sterile concentrate (20 mg per mL) solution for intravenous infusion. The following packaging configurations are available: Individually packaged, single-use vials: NDC 50242-135-01 providing 80 mg per 4 mL
NDC 50242-136-01 providing 200 mg per 10 mL
NDC 50242-137-01 providing 400 mg per 20 mL For Subcutaneous Injection ACTEMRA (tocilizumab) for subcutaneous administration is supplied as a sterile preservative-free liquid solution in a single-use prefilled syringe. The following packaging configurations are available: NDC 50242-138-01 prefilled syringe providing 162 mg per 0.9mL Storage and Stability: Do not use beyond expiration date on the container, package or prefilled syringe. ACTEMRA must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect the vials and syringes from light by storage in the original package until time of use, and keep syringes dry. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If visibly opaque particles, discoloration or other foreign particles are observed, the solution should not be used. Genentech, Inc. A Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080-4990. Revised: October 2013 Last reviewed on RxList: 11/4/2013
This monograph has been modified to include the generic and brand name in many instances.